Review



hla-e car-t  (Cellectis sa)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cellectis sa hla-e car-t
    Latest advances in allo-CAR-T preclinical studies
    Hla E Car T, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hla-e+car-t/hla+e+car+t/pmc11370086-4-0-18
    Average 90 stars, based on 1 article reviews
    hla-e car-t - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Recent updates on allogeneic CAR-T cells in hematological malignancies"

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies

    Journal: Cancer Cell International

    doi: 10.1186/s12935-024-03479-y

    Latest advances in allo-CAR-T preclinical studies
    Figure Legend Snippet: Latest advances in allo-CAR-T preclinical studies

    Techniques Used: Triple Knockout, CRISPR, Expressing, Disruption, Over Expression, Virus

    Related Articles

    Over Expression:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    Triple Knockout:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    CRISPR:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    Expressing:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    Disruption:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    Virus:

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies
    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .



    Similar Products

    anti-cd19 car t cells (with hla-e transgene) pbcar-19b  (Baxalta Inc)
    90
    Baxalta Inc anti-cd19 car t cells (with hla-e transgene) pbcar-19b
    Summary of drugs targeting cell cycle-related proteins and undergoing clinical research. Abbreviations: OS, osteosarcoma; LMS, leiomyosarcoma; SS, synovial sarcoma; OC, ovarian cancer; NSCLC, non-small cell lung cancer; PANC, pancreatic cancer; BC, breast cancer; LC, lung cancer; SCLC, small cell lung cancer; SC, stomach cancer; BCa, bladder cancer; EC, esophageal carcinoma; HNSCC, head and neck squamous cell carcinoma; UC, urothelial carcinoma; PC, prostate cancer; CC, cervical cancer; ECa, endometrial cancer; AST, advanced solid tumor; CRC, colorectal cancer; DTC, differential thyroid cancer; MM, multiple myeloma; PDAC, pancreatic ductal adenocarcinoma; PTC, papillary thyroid cancer.
    Anti Cd19 Car T Cells (With Hla E Transgene) Pbcar 19b, supplied by Baxalta Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hla-e+car-t/anti+cd19+car+t+cells++with+hla+e+transgene++pbcar+19b/pmc11742855-135-0-9
    Average 90 stars, based on 1 article reviews
    anti-cd19 car t cells (with hla-e transgene) pbcar-19b - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    hla-e car-t  (Cellectis sa)
    90
    Cellectis sa hla-e car-t
    Latest advances in allo-CAR-T preclinical studies
    Hla E Car T, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hla-e+car-t/hla+e+car+t/pmc11370086-4-0-18
    Average 90 stars, based on 1 article reviews
    hla-e car-t - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of drugs targeting cell cycle-related proteins and undergoing clinical research. Abbreviations: OS, osteosarcoma; LMS, leiomyosarcoma; SS, synovial sarcoma; OC, ovarian cancer; NSCLC, non-small cell lung cancer; PANC, pancreatic cancer; BC, breast cancer; LC, lung cancer; SCLC, small cell lung cancer; SC, stomach cancer; BCa, bladder cancer; EC, esophageal carcinoma; HNSCC, head and neck squamous cell carcinoma; UC, urothelial carcinoma; PC, prostate cancer; CC, cervical cancer; ECa, endometrial cancer; AST, advanced solid tumor; CRC, colorectal cancer; DTC, differential thyroid cancer; MM, multiple myeloma; PDAC, pancreatic ductal adenocarcinoma; PTC, papillary thyroid cancer.

    Journal: Heliyon

    Article Title: The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors

    doi: 10.1016/j.heliyon.2024.e41457

    Figure Lengend Snippet: Summary of drugs targeting cell cycle-related proteins and undergoing clinical research. Abbreviations: OS, osteosarcoma; LMS, leiomyosarcoma; SS, synovial sarcoma; OC, ovarian cancer; NSCLC, non-small cell lung cancer; PANC, pancreatic cancer; BC, breast cancer; LC, lung cancer; SCLC, small cell lung cancer; SC, stomach cancer; BCa, bladder cancer; EC, esophageal carcinoma; HNSCC, head and neck squamous cell carcinoma; UC, urothelial carcinoma; PC, prostate cancer; CC, cervical cancer; ECa, endometrial cancer; AST, advanced solid tumor; CRC, colorectal cancer; DTC, differential thyroid cancer; MM, multiple myeloma; PDAC, pancreatic ductal adenocarcinoma; PTC, papillary thyroid cancer.

    Article Snippet: Allogeneic anti-CD19 CAR T cells (with HLA-E transgene) , PBCAR-19B(Baxalta/Precision BioSciences) , CD19-expressing malignancies , Phase I , [ ] .

    Techniques: shRNA, CRISPR, Expressing

    Latest advances in allo-CAR-T preclinical studies

    Journal: Cancer Cell International

    Article Title: Recent updates on allogeneic CAR-T cells in hematological malignancies

    doi: 10.1186/s12935-024-03479-y

    Figure Lengend Snippet: Latest advances in allo-CAR-T preclinical studies

    Article Snippet: HLA-E CAR-T , CD22, CD123 , TRAC and B2M K/O and NK inhibitor overexpression , TALEN ® , Cellectis/USA Institut Paoli-Calmettes/Franc , B-cell malignancies , 2022 , [ ] .

    Techniques: Triple Knockout, CRISPR, Expressing, Disruption, Over Expression, Virus